Trophos' Acquisition

Trophos was acquired by Actelion on July 23, 2010.

Trophos is a biopharmaceutical company developing drugs to prevent neuronal loss in patients with neurodegenerative disease. The organization has collaborative research projects on diseases such as sp…

Articles about Trophos' Acquisition: